7-day Via Shalva integrative retreat for breast and gynecologic cancer survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center, observational matched-cohort pilot that runs alongside a 7-day individualized integrative oncology retreat (Via Shalva) at University Hospital Basel. The study measures feasibility outcomes (recruitment, retention, adherence, and data completeness) and collects patient-reported outcomes, wearable-derived physiological data, and biological samples at six time points over six months. Retreat participants are compared with a matched control group who do not attend the retreat to explore preliminary differences in symptoms, wellbeing, and stress-related biomarkers. Findings are intended to inform the design and feasibility of future randomized controlled trials of integrative oncology interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Breast and gynecological cancer (including but not limited to ovarian, endometrial, cervical, vulvar and vaginal cancer) survivors, including recurrent disease
* Completed primary treatment (operation +/- radiation +/- chemotherapy)
* Age ≥ 18 years
* Ongoing or planned maintenance treatment scheduled for \> 3 months during study period is allowed (e.g. antihormonal therapy, Anti-Her2-antibodies, CDK4/6-inhibitors, Anti-VEGF-inhibitor, PARP-inhibitor, immune-checkpoint inhibitors etc.)
* Signed informed consent for participation of the trials
* Presence of a stoma is allowed
* Prior cancer is allowed
* Prior treatment - including chemotherapy - for a prior malignant tumor (including breast or gynecological cancer) is allowed
* Concomitant participation in an experimental therapeutic drug trial is allowed
* Use of other complementary methods (including mistletoe) is allowed
* Pregnancy is allowed.

Exclusion Criteria:

* Language or cognitive deficits (including impaired consciousness) that are incompatible with the participation in the study
* Severe physical or psychiatric comorbidity that prevents a patient from participating in the study
* Patients incapable of giving consent

Where it's running

• University Hospital Basel
  Basel, Switzerland Recruiting

Study contacts

• Study coordinator: Isabell Ge, MD
• Email: Isabellxiang.ge@usb.ch
• Phone: +41 61 32 85885

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Personalized supervised exercise program for adults with breast or gynecologic cancer

  A small pilot study will test a supervised, personalized exercise program to see if it is safe, feasible, and acceptable for adults with a history of breast or gynecologic cancer.

  Recruiting University of Iowa · Iowa City, Iowa · NCT07765927

• High-precision detection of leftover cancer using a liquid-biopsy platform (SHERLOCK)

  This project will test whether sensitive blood and other fluid tests for circulating tumor DNA can find leftover cancer (minimal residual disease) in adults treated with curative intent for breast, lung, melanoma, gynecologic, or genitourinary cancers.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07524114

• Riluzole to prevent thinking and memory problems during chemotherapy

  This pilot trial tests whether riluzole can prevent thinking and memory problems in adults with cancer receiving anthracycline- or platinum-based chemotherapy.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT07447050

• Web app for reporting side effects during radiation therapy

  This project will try a web app that lets people receiving radiation for breast, gynecologic, or urologic cancers report symptoms and quality of life so clinicians can spot problems earlier.

  Recruiting Institute of Oncology Ljubljana · Ljubljana · NCT07416630

• Guided meditation during radiation for breast and gynecologic cancers

  This project will test whether short guided meditations played during daily radiation can reduce anxiety for adults receiving radiation for breast or gynecologic cancer.

  Recruiting Phase 3 University of Utah · Salt Lake City, Utah · NCT07166042

• Florida ASCENT Program

  This project will test whether combining the MyCarePulse EHR platform with ASCENT patient navigators helps adults with recent cancer diagnoses in Florida improve food security, diet quality, and confidence in healthy eating compared with standard care.

  Recruiting University of Florida · Gainesville, Florida · NCT07042243

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.